H2S Donor S-Propargyl-Cysteine Shows Anti-Cancer Effects in Gastric Cancer
Author Information
Author(s): MA Kaium, Liu Yan, Zhu Qing, Liu Chun-hua, Duan Jun-Li, Tan Benny K-H., Zhu Yi Zhun
Primary Institution: Fudan University, Shanghai, China
Hypothesis
Does S-propargyl-cysteine (SPRC) have an anti-cancer effect on gastric cancer cells and tumors?
Conclusion
The study found that SPRC has a significant anti-cancer effect on gastric cancer by inducing apoptosis and inhibiting tumor growth.
Supporting Evidence
- SPRC treatment significantly decreased cell viability and suppressed the proliferation of gastric cancer cells.
- SPRC induced apoptosis in cancer tissues and elevated expressions of p53 and Bax.
- SPRC treatment increased CSE activity and H2S levels in both cell culture media and plasma of mice.
Takeaway
A special compound called SPRC can help fight stomach cancer by making cancer cells die and stopping them from growing.
Methodology
The study used both in vitro (cell culture) and in vivo (nude mice) experiments to assess the effects of SPRC on gastric cancer cells and tumors.
Limitations
The study was conducted on a specific type of cancer cells and animal models, which may not fully represent human gastric cancer.
Participant Demographics
Male nude mice were used for in vivo studies.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website